Cargando…

Cutaneous Findings in Neurofibromatosis Type 1

SIMPLE SUMMARY: Neurofibromatosis type 1 (NF1) is characterized by major and minor cutaneous findings, whose recognition plays a key role in the early diagnosis of the disease. The disease affects multiple systems and clinical manifestation has a wide range of variability. Symptoms and clinical sign...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozarslan, Bengisu, Russo, Teresa, Argenziano, Giuseppe, Santoro, Claudia, Piccolo, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865571/
https://www.ncbi.nlm.nih.gov/pubmed/33530415
http://dx.doi.org/10.3390/cancers13030463
_version_ 1783647877479792640
author Ozarslan, Bengisu
Russo, Teresa
Argenziano, Giuseppe
Santoro, Claudia
Piccolo, Vincenzo
author_facet Ozarslan, Bengisu
Russo, Teresa
Argenziano, Giuseppe
Santoro, Claudia
Piccolo, Vincenzo
author_sort Ozarslan, Bengisu
collection PubMed
description SIMPLE SUMMARY: Neurofibromatosis type 1 (NF1) is characterized by major and minor cutaneous findings, whose recognition plays a key role in the early diagnosis of the disease. The disease affects multiple systems and clinical manifestation has a wide range of variability. Symptoms and clinical signs may occur over the lifetime, and the complications are very diverse. Although significant progress has been made in understanding the pathophysiology of the disease, no specific treatment has been defined. Multidisciplinary approach is required to provide optimum care for the patients. The aim of this paper is to provide the clinician with a complete guide of skin findings of NF1. ABSTRACT: Neurofibromatosis type 1 (NF1) is a complex autosomal dominant disorder associated with germline mutations in the NF1 tumor suppressor gene. NF1 belongs to a class of congenital anomaly syndromes called RASopathies, a group of rare genetic conditions caused by mutations in the Ras/mitogen-activated protein kinase pathway. Generally, NF1 patients present with dermatologic manifestations. In this review the main features of café-au-lait macules, freckling, neurofibromas, juvenile xanthogranuloma, nevus anemicus and other cutaneous findings will be discussed.
format Online
Article
Text
id pubmed-7865571
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78655712021-02-07 Cutaneous Findings in Neurofibromatosis Type 1 Ozarslan, Bengisu Russo, Teresa Argenziano, Giuseppe Santoro, Claudia Piccolo, Vincenzo Cancers (Basel) Review SIMPLE SUMMARY: Neurofibromatosis type 1 (NF1) is characterized by major and minor cutaneous findings, whose recognition plays a key role in the early diagnosis of the disease. The disease affects multiple systems and clinical manifestation has a wide range of variability. Symptoms and clinical signs may occur over the lifetime, and the complications are very diverse. Although significant progress has been made in understanding the pathophysiology of the disease, no specific treatment has been defined. Multidisciplinary approach is required to provide optimum care for the patients. The aim of this paper is to provide the clinician with a complete guide of skin findings of NF1. ABSTRACT: Neurofibromatosis type 1 (NF1) is a complex autosomal dominant disorder associated with germline mutations in the NF1 tumor suppressor gene. NF1 belongs to a class of congenital anomaly syndromes called RASopathies, a group of rare genetic conditions caused by mutations in the Ras/mitogen-activated protein kinase pathway. Generally, NF1 patients present with dermatologic manifestations. In this review the main features of café-au-lait macules, freckling, neurofibromas, juvenile xanthogranuloma, nevus anemicus and other cutaneous findings will be discussed. MDPI 2021-01-26 /pmc/articles/PMC7865571/ /pubmed/33530415 http://dx.doi.org/10.3390/cancers13030463 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Ozarslan, Bengisu
Russo, Teresa
Argenziano, Giuseppe
Santoro, Claudia
Piccolo, Vincenzo
Cutaneous Findings in Neurofibromatosis Type 1
title Cutaneous Findings in Neurofibromatosis Type 1
title_full Cutaneous Findings in Neurofibromatosis Type 1
title_fullStr Cutaneous Findings in Neurofibromatosis Type 1
title_full_unstemmed Cutaneous Findings in Neurofibromatosis Type 1
title_short Cutaneous Findings in Neurofibromatosis Type 1
title_sort cutaneous findings in neurofibromatosis type 1
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865571/
https://www.ncbi.nlm.nih.gov/pubmed/33530415
http://dx.doi.org/10.3390/cancers13030463
work_keys_str_mv AT ozarslanbengisu cutaneousfindingsinneurofibromatosistype1
AT russoteresa cutaneousfindingsinneurofibromatosistype1
AT argenzianogiuseppe cutaneousfindingsinneurofibromatosistype1
AT santoroclaudia cutaneousfindingsinneurofibromatosistype1
AT piccolovincenzo cutaneousfindingsinneurofibromatosistype1